Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma
Thongprasert, S., Napapan, S., Charoentum, C., Moonprakan, S.
Published in Annals of oncology (01.02.2005)
Published in Annals of oncology (01.02.2005)
Get full text
Journal Article
HALO 110-101: Phase Ib study of PEGPH20 in combination with cisplatin + gemcitabine (PEGCISGEM) or atezolizumab (ATEZO) + CIS + GEM (PEGCISGEMATEZO) in patients with locally advanced/metastatic cholangiocarcinoma and gallbladder cancer
Oh, D.-Y., Park, J.-O., Charoentum, C., Stein, S., Noel, M., Chung, V., Wu, W., Alton, R., Muhsin, M., Javle, M., Abou-Alfa, G.K., Borad, M.J.
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
3044 Epidermal growth factor receptor mutations in unselected advanced non-small cell lung cancers in Thai patients
Charoentum, C, Lertprasertsuke, N, Phanthunane, C, Theerakittikul, T, Liwsrisakun, C, Saeteng, S, Tantraworasin, A, Suksombooncharoen, T, Chewaskulyong, B, Thongprasert, S
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer
Chen, L.-T., Vogel, A., Hsu, C., Chen, M.-H., Fang, W., Pangarsa, E.A., Sharma, A., Ikeda, M., Park, J.O., Tan, C.K., Regala, E., Tai, D., Tanasanvimon, S., Charoentum, C., Chee, C.E., Lui, A., Sow, J., Oh, D.-Y., Ueno, M., Ramaswamy, A., Jeo, W.S., Zhou, J., Curigliano, G., Yoshino, T., Bai, L.-Y., Pentheroudakis, G., Chiang, N.-J., Cervantes, A., Chen, J.-S., Ducreux, M.
Published in ESMO open (01.08.2024)
Published in ESMO open (01.08.2024)
Get full text
Journal Article
P-218 FOLFIRI as third- or later-line treatment for advanced biliary tract cancer in Northern Thailand
Thanasombunsukh, K., Wittayachumnangul, B., Charoentum, C.
Published in Annals of oncology (01.06.2022)
Published in Annals of oncology (01.06.2022)
Get full text
Journal Article
EP10.01-09 Added Serum Albumin to Lung-mol GPA Score Improves Prediction of Overall Survival in Non-Small Cell Lung Cancer Patients with Brain Metastasis
Pinthaya, C., Charoentum, C., Suksombooncharoen, T., Chewaskulyong, B.C., Ketpueak, T.
Published in Journal of thoracic oncology (01.11.2023)
Published in Journal of thoracic oncology (01.11.2023)
Get full text
Journal Article
EP08.02-026 Real-world Efficacy of EGFR-TKI in Advanced NSCLC and Clinical Predictors of Outcome in Maharaj Nakorn Chiangmai Hospital in Thailand
Charoentum, C., Nasit, K., Ketpueak, T., Suksombooncharoen, T., Chewaskulyong, B.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article
EP08.04-003 A Simple Clinical Prediction Score to Determine Response to First Line Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer Patients
Chayangsu, C., Charoentum, C., Sriuranpong, V., Tantraworasin, A.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article
PCN101 Healthcare Resource Utilization, Costs, and Clinical Outcomes in Patients with Triple-Negative Breast Cancer in Northern Thailand: A Real World Evidence Using Electronic Health Records
Charoentum, C., Chitapanarux, I., Sangroongruangsri, S.
Published in Value in health regional issues (01.09.2020)
Published in Value in health regional issues (01.09.2020)
Get full text
Journal Article
1084P Cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma (mCSCC): Preliminary safety and efficacy results from a phase I clinical trial
Clingan, P., Brungs, D., Ladwa, R., Mant, A.M., McGrath, M., Tazbirkova, A., Koralewski, P., Lugowska, I., Charoentum, C., Dechaphunkul, A., Sriuranpong, V., Oliviero, J., Harris, D.L.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
MA12.07 Amivantamab Plus Lazertinib vs Osimertinib in First-Line, EGFR-Mutant Advanced NSCLC: Patient-relevant Outcomes from MARIPOSA
Nguyen, D., Besse, B., Cho, B.C., Lee, S.-H., Lee, K.H., Lu, S., Cheng, Y., Yao, Y., Girard, N., Lin, C.-C., Felip, E., Aguilar, A., Charoentum, C., Cruz, F.J.S.M., Majem, M., Lim, C.S., Akamatsu, H., Hayashi, H., Yang, J.C.-H., Kowalyszyn, R., Tiscoski, K., Franke, F., Ponomarenko, D., Arslan, C., Forster, M., Urban, D., Misch, D., Delmonte, A., Montes, L.V.G., Gadgeel, S.M., Cruz-Correa, M., Peguero, J., Rousey, S., Gaffar, Y., Owen, S., Schuchard, J., Diels, J., Sermon, J., Sun, T., Ennis, M., Fennema, E., Daksh, M., Sethi, S., Bauml, J.M., Campelo, M.R. Garcia
Published in Journal of thoracic oncology (01.10.2024)
Published in Journal of thoracic oncology (01.10.2024)
Get full text
Journal Article
A Phase Ib Study of IMU-131 HER2/neu peptide vaccine plus chemotherapy in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction
Chao, Y., Maglakelidze, M., Bulat, L.V., Yau, T., Tanasanvimon, S., Charoentum, C., Arpornwirat, W., Maneechavakajorn, J., Dechaphunkul, A., Ungtrakul, T., Yen, C.-J., Bai, L.-Y., Chou, W.-C., Weidermann, U., Garner-Spitzer, E., Ede, N., Chong, L., Good, A.
Published in Annals of oncology (01.11.2019)
Published in Annals of oncology (01.11.2019)
Get full text
Journal Article
Safety, efficacy, and pharmacokinetic (PK) profile of cosibelimab, an anti‐PD‐L1 antibody, in patients (pts) with advanced cancers
Clingan, P.R., Mant, A.M., Richardson, G.E., Kowalski, D.M., Koralewski, P., Lugowska, I., Dechaphunkul, A., Charoentum, C., Sookprasert, A., Sriuranpong, V., Akopov, A., Kozlov, V., Fadeeva, N., Kasparov, B., Kovalenko, N.V., Oschepkov, V., Gorelik, L., Kunes, Y., Oliviero, J., Harris, D.L.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
469P - Safety, efficacy, and pharmacokinetic (PK) profile of cosibelimab, an anti‐PD‐L1 antibody, in patients (pts) with advanced cancers
Clingan, P.R., Mant, A.M., Richardson, G.E., Kowalski, D.M., Koralewski, P., Lugowska, I., Dechaphunkul, A., Charoentum, C., Sookprasert, A., Sriuranpong, V., Akopov, A., Kozlov, V., Fadeeva, N., Kasparov, B., Kovalenko, N.V., Oschepkov, V., Gorelik, L., Kunes, Y., Oliviero, J., Harris, D.L.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
211TiPHALO 110-101: Phase Ib study of PEGPH20 in combination with cisplatin + gemcitabine (PEGCISGEM) or atezolizumab (ATEZO) + CIS + GEM (PEGCISGEMATEZO) in patients with locally advanced/metastatic cholangiocarcinoma and gallbladder cancer
Oh, D-Y, Park, J-O, Charoentum, C, Stein, S, Noel, M, Chung, V, Wu, W, Alton, R, Muhsin, M, Javle, M, Abou-Alfa, G K, Borad, M J
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
469PSafety, efficacy, and pharmacokinetic (PK) profile of cosibelimab, an anti‐PD‐L1 antibody, in patients (pts) with advanced cancers
Clingan, P R, Mant, A M, Richardson, G E, Kowalski, D M, Koralewski, P, Lugowska, I, Dechaphunkul, A, Charoentum, C, Sookprasert, A, Sriuranpong, V, Akopov, A, Kozlov, V, Fadeeva, N, Kasparov, B, Kovalenko, N V, Oschepkov, V, Gorelik, L, Kunes, Y, Oliviero, J, Harris, D L
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1212P - Comprehensive results of a phase Ib study with a HER2/neu B-cell peptide vaccine administered with cisplatin and 5-fluorouracil or capecitabine chemotherapy show safety, immunogenicity and clinical response in patients with HER2/Neu overexpressing advanced gastric cancer
Wiedermann, U., Garner-Spitzer, E., Chao, Y., Bulat, I., Dechaphunkul, A., Arpornwirat, W., Charoentum, C., Yen, C.J., Yau, T., Maglakelidzde, M., Tanasanvimon, S., Maneechavakajorn, J., Sookprasert, A., Bai, L.-Y., Chou, W.-C., Ungtrakul, T., Zielinski, C.C., Chong, L., Ede, N., Good, A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1212PComprehensive results of a phase Ib study with a HER2/neu B-cell peptide vaccine administered with cisplatin and 5-fluorouracil or capecitabine chemotherapy show safety, immunogenicity and clinical response in patients with HER2/Neu overexpressing advanced gastric cancer
Wiedermann, U, Garner-Spitzer, E, Chao, Y, Bulat, I, Dechaphunkul, A, Arpornwirat, W, Charoentum, C, Yen, C J, Yau, T, Maglakelidzde, M, Tanasanvimon, S, Maneechavakajorn, J, Sookprasert, A, Bai, L-Y, Chou, W-C, Ungtrakul, T, Zielinski, C C, Chong, L, Ede, N, Good, A
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article